Provided by Tiger Trade Technology Pte. Ltd.

INmune Bio Inc

2.32
+0.16007.41%
Post-market: 2.30-0.0200-0.86%19:31 EDT
Volume:520.14K
Turnover:1.18M
Market Cap:64.39M
PE:-3.34
High:2.34
Open:2.22
Low:2.19
Close:2.16
52wk High:2.44
52wk Low:1.09
Shares:27.75M
Float Shares:23.19M
Volume Ratio:1.46
T/O Rate:2.24%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.6937
EPS(LYR):-1.8600
ROE:-74.82%
ROA:-39.12%
PB:3.16
PE(LYR):-1.25

Loading ...

Sector Update: Healthcare Stocks Edge Higher Premarket Wednesday

MT Newswires Live
·
Jul 01

INmune Bio Files US Patent Application for CORDStrom Cell Therapy Platform

MT Newswires Live
·
Jul 01

INmune Bio advances CORDStrom platform patent application in the U.S.

TIPRANKS
·
Jul 01

Inmune Bio Says Holders Exercise 647,112 Warrants at $1.4 Per Share Under Inducement Offer

Reuters
·
Jul 01

INmune Bio Advances CORDStrom™ Platform Patent Application in the U.S. Following Favorable International Written Opinion

GlobeNewswire
·
Jul 01

Inmune Bio Wins MHRA Pediatric Plan Approval for Ebstrocel in RDEB

Reuters
·
Jun 25

Inmune Bio Inc. Achieves Mhra Approval of Pip for Cordstrom™

THOMSON REUTERS
·
Jun 25

Inmune Bio - UK Mhra Approves Pediatric Investigation Plan for Ebstrocel for Rdeb

THOMSON REUTERS
·
Jun 25

Inmune Bio - Preparing for Maa Submission and Final Manufacturing for Ebstrocel

THOMSON REUTERS
·
Jun 25

INmune Bio Inc. Achieves MHRA Approval of PIP for CORDStrom™

GlobeNewswire
·
Jun 25

Analysts Are Bullish on These Healthcare Stocks: Inmune Bio (INMB), AbSci (ABSI)

TIPRANKS
·
Jun 25

INmune Bio announces MHRA alignment in pre-MAA CORDStrom meeting

TIPRANKS
·
Jun 24

INmune Bio's CORDStrom Gets Written Alignment on UK Conditional Marketing Authorization Application

MT Newswires Live
·
Jun 23

INmune Bio - Mhra Affirms INmune Bio's Pooled-Donor Approach as Acceptable

THOMSON REUTERS
·
Jun 23

INmune Bio: Advancing Final Commercial Manufacturing Validation Activities & Dossier Compilation to Support Planned UK Submission

THOMSON REUTERS
·
Jun 23

INmune Bio Receives Mhra Written Alignment Supporting Planned 2026 UK Conditional Marketing Authorization Application for Cordstrom™ in Rdeb

THOMSON REUTERS
·
Jun 23

INmune Bio Receives MHRA Written Alignment Supporting Planned 2026 UK Conditional Marketing Authorization Application for CORDStrom™ in RDEB

GlobeNewswire
·
Jun 23

INmune Bio shareholders back amended 2021 stock incentive plan, boosting share pool to 9,158,525

Reuters
·
Jun 18

INmune Bio reports positive MRI data in Phase 2 Alzheimer’s trial

TIPRANKS
·
Jun 02

INmune Bio - Xpro1595 Efficacy Strengthened in Biomarker-Enriched Patients With Elevated Inflammation

THOMSON REUTERS
·
Jun 02